Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)
33.87
-0.24 (-0.70%)
At close: Feb 5, 2026
ASX:FPH Market Cap
ASX:FPH has a market cap or net worth of 20.11 billion as of February 5, 2026. Its market cap has decreased by -0.77% in one year.
Market Cap
20.11B
Enterprise Value
19.98B
Revenue
1.89B
Ranking
n/a
PE Ratio
52.48
Stock Price
33.87
Market Cap Chart
Since February 28, 1992, ASX:FPH's market cap has increased from 173.53M to 20.11B, an increase of 11,488.04%. That is a compound annual growth rate of 15.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 20.14B | 5.30% |
| Dec 31, 2025 | 19.12B | -6.12% |
| Dec 31, 2024 | 20.37B | 59.11% |
| Dec 29, 2023 | 12.80B | 4.87% |
| Dec 30, 2022 | 12.21B | -31.40% |
| Dec 31, 2021 | 17.79B | 0.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 87.60B |
| Pro Medicus | 17.38B |
| Cochlear | 17.00B |
| Sonic Healthcare | 11.15B |
| Ramsay Health Care | 8.18B |
| Ansell | 4.63B |
| Telix Pharmaceuticals | 3.43B |
| Mesoblast | 3.19B |